Procter & Gamble (NYSE:PG) Issues FY25 Earnings Guidance

Procter & Gamble (NYSE:PGGet Free Report) updated its FY25 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $6.91-7.05 for the period, compared to the consensus estimate of $6.96. The company issued revenue guidance of ~$85.7-87.4 billion, compared to the consensus revenue estimate of $86.79 billion. Procter & Gamble also updated its FY 2025 guidance to 6.910-7.050 EPS.

Wall Street Analysts Forecast Growth

PG has been the topic of a number of recent research reports. JPMorgan Chase & Co. dropped their price target on Procter & Gamble from $181.00 to $179.00 and set an overweight rating on the stock in a research report on Wednesday. Evercore ISI increased their target price on Procter & Gamble from $177.00 to $183.00 and gave the stock an outperform rating in a research report on Thursday, July 18th. Royal Bank of Canada lifted their price target on Procter & Gamble from $157.00 to $164.00 and gave the company a sector perform rating in a research report on Wednesday. TD Cowen began coverage on shares of Procter & Gamble in a research report on Tuesday, July 23rd. They issued a buy rating and a $189.00 price objective for the company. Finally, Argus upped their target price on shares of Procter & Gamble from $180.00 to $185.00 and gave the stock a buy rating in a report on Thursday, April 25th. Eight equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat.com, Procter & Gamble currently has an average rating of Moderate Buy and a consensus price target of $173.95.

Check Out Our Latest Research Report on PG

Procter & Gamble Stock Performance

Shares of NYSE:PG opened at $168.85 on Friday. The company has a current ratio of 0.73, a quick ratio of 0.48 and a debt-to-equity ratio of 0.50. The company has a market cap of $398.51 billion, a price-to-earnings ratio of 27.07, a price-to-earnings-growth ratio of 3.02 and a beta of 0.41. Procter & Gamble has a 12 month low of $141.45 and a 12 month high of $170.92. The company has a 50-day moving average price of $166.18 and a 200-day moving average price of $161.91.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings results on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, beating analysts’ consensus estimates of $1.37 by $0.03. Procter & Gamble had a return on equity of 33.33% and a net margin of 17.71%. The business had revenue of $20.53 billion during the quarter, compared to analyst estimates of $20.69 billion. During the same quarter in the prior year, the company posted $1.37 EPS. Procter & Gamble’s quarterly revenue was down .1% compared to the same quarter last year. As a group, equities analysts anticipate that Procter & Gamble will post 6.97 EPS for the current year.

Procter & Gamble Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be given a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a dividend yield of 2.38%. The ex-dividend date of this dividend is Friday, July 19th. Procter & Gamble’s dividend payout ratio is currently 65.85%.

Insiders Place Their Bets

In other Procter & Gamble news, insider Moses Victor Javier Aguilar sold 9,149 shares of the company’s stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $167.72, for a total transaction of $1,534,470.28. Following the transaction, the insider now owns 12,929 shares in the company, valued at approximately $2,168,451.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, COO Shailesh Jejurikar sold 31,859 shares of the company’s stock in a transaction that occurred on Monday, May 6th. The stock was sold at an average price of $164.90, for a total value of $5,253,549.10. Following the sale, the chief operating officer now owns 9,739 shares in the company, valued at approximately $1,605,961.10. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Moses Victor Javier Aguilar sold 9,149 shares of Procter & Gamble stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $167.72, for a total value of $1,534,470.28. Following the transaction, the insider now owns 12,929 shares of the company’s stock, valued at approximately $2,168,451.88. The disclosure for this sale can be found here. Insiders sold 94,320 shares of company stock worth $15,646,323 over the last three months. Company insiders own 0.17% of the company’s stock.

Procter & Gamble Company Profile

(Get Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Read More

Earnings History and Estimates for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.